Example: Heart Attack

Clinical Trials on Liver Neoplasms

Total 2999 results

    • NCT02729493
      Unknown status
      Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer
      Conditions: Liver Neoplasms
    • NCT00584402
      Completed
      Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
      Conditions: Liver Neoplasms
    • NCT03045952
      Unknown status
      Percutaneous Microwave Ablation Under Ultrasound Guidance for Liver Cancer: a Multicenter Analysis
      Conditions: Liver Neoplasms
    • NCT02018107
      Completed
      PET/CT-Assessment of Liver Tumor Ablation
      Conditions: Liver Tumor; Liver Neoplasms
    • NCT02501980
      Active, not recruiting
      Hepatocellular Cancer (HCC) Screening in Zhongshan City
      Conditions: Liver Neoplasms
    • NCT00922181
      Completed
      Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer
      Conditions: Liver Neoplasms
    • NCT02827786
      Unknown status
      Feasibility of Electromagnetic Acoustic Imaging of Liver Tumours
      Conditions: Liver Tumours
    • NCT03183219
      Completed
      Safety and Efficiency of γδ T Cell Against Liver Cancer
      Conditions: Liver Cancer
    • NCT04309747
      Not yet recruiting
      A Prospective, Multicenter Clinical Trial of Safety and Effectiveness of Nanosecond Knife Ablation for Liver Cancer
      Conditions: Liver Cancer
    • NCT03297255
      Recruiting
      Primary Liver Cancer Cohort of South China
      Conditions: Primary Liver Cancer
    • NCT04413526
      Recruiting
      Radiofrequency-assisted Liver Resection in Intractable Liver Cancer
      Conditions: Liver Cancer
    • NCT02425735
      Completed
      Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer
      Conditions: Liver Cancer
    • NCT01281943
      Withdrawn
      Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
      Conditions: Liver Neoplasms
    • NCT01877187
      Completed
      Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
      Conditions: Liver Cancer
    • NCT02447263
      Completed
      HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer
      Conditions: Liver Cancer
    • NCT02545556
      Completed
      Liver Cancer HepaSphere Combined With Cryosurgery
      Conditions: Liver Cancer
    • NCT02291133
      Completed
      Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)
      Conditions: Liver Cancer
    • NCT04272619
      Recruiting
      Liver Cancer Community Education
      Conditions: Liver Cancer
    • NCT04409340
      Recruiting
      Viscoelasticity Imaging to Assess Liver Cancer
      Conditions: Liver Cancer
    • NCT04274868
      Recruiting
      Pediatric Hepatic Tumors
      Conditions: Liver Tumor
    • NCT00422877
      Terminated
      Taxoprexin® Treatment for Advanced Primary Cancers of the Liver
      Conditions: Cancer of the Liver
    • NCT00020774
      Withdrawn
      SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
      Conditions: Liver Cancer
    • NCT00899002
      Withdrawn
      Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
      Conditions: Liver Cancer
    • NCT03484962
      Withdrawn
      Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer
      Conditions: Advanced Liver Cancer
    • NCT03146637
      Recruiting
      Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer
      Conditions: Advanced Liver Cancer
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations